A range of new mental health treatments are available to Western medicine, and practitioners are figuring out how to use them effectively. Matt Brockmeier, co-founder and chief legal officer at Entheogyn and of counsel at Antithesis Law, joins Rebecca Nicholson, foundation director and wellness advisor at Prime Quadrant, to explore this evolving landscape with McGuireWoods partner and host Geoff Cockrell.

Matt discusses the tension between state and federal laws shaping access to psychedelics and controlled substances, while Rebecca contrasts the investment dynamics of cannabis versus psychedelics, emphasizing mental health over recreation. They examine specialized investor appetite, the medical community’s evolving response and the ancillary wellness modalities supporting comprehensive mental health transformation.

Patient Square Capital has announced its acquisition of Premier Inc.

Premier, formed in 1996 and based in Charlotte, North Carolina, is a healthcare service company well known for its group purchasing organization services, but also offering technology, data analytics, advisory and performance improvement solutions.

Patient Square, based in Menlo Park, Calif., is dedicated healthcare investment firm. Founded in 2020, the firm seeks investments across several healthcare industry subsectors, including products, services and technologies designed to improve health.

The transaction was valued at $2.6 billion. With the completion of the acquisition, Premier’s common stock ceased trading and was delisted from Nasdaq.

Patient Square had announced its intention to acquire Premier in September.

Vance Street Capital has announced its acquisition of Injectech from The West Group (TWG).

Injectech, founded in 1998 and based in Fort Collins, Colorado, is a manufacturer of luer locks, bond-in luers, check valves, tube to tube connectors and spikes for the medical industry.

Vance Street, founded in 2007 and based in Los Angeles, is a middle market private equity firm that invests in several sectors, including medical technology and life science. The firm typically pursues companies with between $3 million and $30 million in EBITDA and with an enterprise value of $30 million to $350 million operating in the United States and Canada.

TWG is a U.K.-based company that specializes in the design and supply of fluid components and solutions to the medical and scientific markets.

Terms of the transaction were not disclosed.

H.I.G. Capital has announced an investment in GT Independence.

GT, founded in 2004 and based in Sturgis, Michigan, is a provider of long-term home care and support solutions for Medicaid participants.

H.I.G., founded in 1993 and based in Miami, pursues a wide range of investments in healthcare and many other industries. The firm has flexibility on investment size, including interest in pre-EBITDA businesses. Within healthcare, the firm targets companies in the provider services, hospital/major facilities and life sciences/pharmaceutical industries.

Terms of the investment were not disclosed.

Sheridan Capital Partners has sold Tarrytown Expocare Pharmacy to Carlyle, according to a news release.

Tarrytown, founded in 2007 and based in Austin, Texas, is a long-term care pharmacy specialized in serving individuals with intellectual and developmental disabilities. The company states that it is licensed in more than 40 states.

Sheridan, founded in 2012 and based in Chicago, is healthcare-focused firm that concentrates on the lower middle market. The firm pursues buyouts and growth equity investments in providers and provider services, healthcare IT and outsourced services, and consumer health and medical products.

Carlyle (NASDAQ: CG), founded in 1987 and with its U.S. headquarters in Washington, D.C., is a global investment firm that deploys private capital across three business segments: global private equity, global credit and investment solutions. The firm targets companies in healthcare and many other industries.

Sheridan will retain a minority ownership position in Tarrytown.

Terms of the transaction were not disclosed.

One Equity Partners (OEP) has announced the exit from its investment in InfuCare Rx through a strategic founder-led equity buyback.

InfuCare, founded in 2014 and based in Fairfield, New Jersey, is a specialty infusion therapy services provider for patients with complex conditions.

OEP, founded in 2001 and based in New York, is a middle market private equity firm that targets investments in healthcare and a few other sectors. OEP seeks control-oriented investments with flexible structure in North American and Western Europeans companies with revenue between $100 million and $750 million and EBITDA of $10 million to $150 million.

Terms of the transaction were not disclosed.

Diversis Capital has announced the acquisitions of three technology companies serving the hospital supply chain management market:

  • Kermit, a cloud-based, bill-only automation, spend-management and analytics platform for physician preference items;
  • Meperia, a supply chain and procurement intelligence platform; and
  • Genesis Automation Healthcare, a clinical traceability and supply chain automation solution.

The combined three companies will be unified under the Genesis brand.

Diversis, founded in 2013 and based in Los Angeles, is a lower middle market technology investment firm.

Terms of the transactions were not disclosed.

JLL Partners has announced its acquisition of Parks Medical Electronics.

Parks, established in 1961 and based in Aloha, Oregon, is a manufacturer of Doppler ultrasound systems and vascular labs. Its products, including the Flo-Lab system, are used in medical offices, operating rooms and veterinary practices. 

JLL, founded in 1988 and based in New York, is a middle market private equity firm that targets companies in healthcare and a few other sectors.

Terms of the acquisition were not disclosed.

JLL also announced it would be combining Parks with Vascular Technology Inc., which the firm acquired earlier in the year.

WindRose Health Investors has announced it completed the sale of BPD Healthcare to MJH Life Sciences.

BPD, founded in 2002 and based in Boca Raton, Florida, is a healthcare marketing services firm.

WindRose, founded in 2000 and based in New York, pursues equity investments in healthcare companies. The firm invests in a broad range of industry segments, including outsourced services to payors and health systems, technology-enabled services, healthcare providers and value-added distribution.

MJH, founded in 1988 and based in Monroe, New Jersey, is a medical media company.

Terms of the transaction were not disclosed.

TPG and Blackstone will acquire Hologic, according to a news release. The deal is valued at up to $18.3 billion.

Hologic (Nasdaq: HOLX), founded in 1985 and based in Marlborough, Massachusetts, is a women’s health technology firm.

TPG, founded in 1992 and based in San Francisco, targets investments in middle market companies. The firm invests in healthcare and a number of other industries.

Blackstone, founded in 1985 and based in New York, is one of the largest global alternative asset managers.

The transaction is expected to close in the first half of 2026. Upon completion of the transaction, Hologic’s common stock will be delisted from the Nasdaq.